New registry to track prostate cancer focal therapy results

This study is a registry that collects information from 1,000 men with prostate cancer who receive focal therapy using high-intensity focused ultrasound (HIFU) or irreversible electroporation (IRE). No new treatment is given—researchers simply record patient details, disease features, and treatment results to understand long-term success rates. The goal is to improve future treatment decisions for prostate cancer.